secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0001731122-24-001606
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro appoints new CEO David Weinstein; multiple board resignations including chairman
--------------------------------------------------------------------------------

- David Weinstein (age 64) appointed CEO and board member; base salary $400k, up to $150k bonus, 250k restricted shares, 1.6M stock options.
- Former CEO Mark Dybul resigned Oct 12, 2024; eight directors resigned between Oct 11-15, including chairman Rene Sindlev.
- New directors appointed: Maurice van Tilburg, James McNulty, Douglas Calder, Mark Collins.
- Weinstein receives $25k bonus if company secures $2M+ in new financing; severance includes 6 months' salary and accelerated equity vesting.
- Resignations by James Sapirstein, Gregg Alton, Jayne McNicol, Carol Brosgart were by letters; no disagreements cited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/0001731122-24-001606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001606/e6034_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer